-
Pharma to benefit from FDA digital health regulations
europeanpharmaceuticalreview
April 02, 2019
Companies that invest heavily now stand to steal a lasting lead over rivals that hesitate…
-
Pharma taps new CEO just as it unveils a big tie-up with AstraZeneca
fiercepharma
April 02, 2019
Only a month after making one set of?senior-level management changes, Daiichi Sankyo has decided it’s the right time to change its CEO as well.
-
Bormioli Pharma Strengthens U.S. Presence
contractpharma
March 28, 2019
Pharma packaging manufacturer has established a new legal entity in the U.S.
-
HC seeks Centre’s reply on PETA plea against use of horses for producing anti-venoms
expressbpd
March 21, 2019
People for the Ethical Treatment of Animals (PETA) has sought directions to the Centre to exclude animal-based production techniques wherever an alternate mechanism is available
-
C2 Pharma acquires Digoxin API Portfolio from Nobilus Ent to guarantee long-term quality and supply chain security
expressbpd
March 20, 2019
A fully redundant supply of Digoxin API from C2 PHARMA will be available via two CMO manufacturing sources at Nobilus in Poland and Laurus Labs in India
-
Pall Enters Cell and Gene Therapy Mfg. Tie-up with NJII
contractpharma
March 20, 2019
New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology (NJIT) Corporation, has signed an Industry Participation Agreement with?Pall Corporation?to support the development of its BioPharmaceutical Innovation iLab.
-
Paratek Pharma Management Change
contractpharma
March 19, 2019
Douglas Pagán resigns as CFO, Sarah Higgins to assume responsibilities on interim basis.
-
Sheba, Lonza Collaborate on Cell Therapy Mfg. Platform
contractpharma
March 19, 2019
Will assess automated CAR-T cell therapy manufacturing at the point-of-care.
-
Project launched to tackle lab inefficiency, support AI adoption
europeanpharmaceuticalreview
March 13, 2019
A project backed by major pharma will advance the Lab of the Future with proof of concept software to digitise experiment methods…
-
AbbVie and Pfizer return to the top of pharma's TV spending list for February
fiercepharma
March 08, 2019
AbbVie’s Humira is back—at the top of the pharma TV ad spending pile, that is. In February, Humira was the No. 1 spender again, according to data from real-time TV ad tracker iSpot.tv, swapping places with Pfizer’s?Xeljanz.